Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Alzheimer Disease Clinical Trial
GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
Status: Enrolling, Phase
Updated: 12/31/1969
University of Miami Center on Aging
mi
from
Miami, FL
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
Status: Enrolling, Phase
Updated: 12/31/1969
Clarity Clinical Research, LLC
mi
from
Syracuse, NY
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling, Phase III
Updated: 12/31/1969
UZ Leuven
mi
from
Leuven,
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Cancer and Blood Specialists
mi
from
East Setauket, NY
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center-Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hematology Oncology Center of Nyack Hospital
mi
from
Nyack, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Trident Medical Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
DaVita Medical Group
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
UP Health System- Marquette
mi
from
Marquette, MI
Click here to add this to my saved trials
Neoplasms, Advanced or Metastatic Clinical Trial
MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
Status: Enrolling, Phase I
Updated: 3/22/2016
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
Neoplasms, Advanced or Metastatic Clinical Trial
MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
Status: Enrolling, Phase I
Updated: 3/22/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Munster, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Coronado, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Hillsborough, NJ
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia
Status: Enrolling, Phase I
Updated: 12/16/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients
Status: Enrolling, Phase I
Updated: 7/14/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Wisconsin Wisconsin Dialysis Institute
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center ( Site 1229)
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Cullman, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lenexa, KS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Naples, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanatorio Britanico
mi
from
Rosario,
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Fairview Park, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Status: Enrolling
Updated: 12/31/1969
NYU Winthrop Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Cardiac Transplant Disorder Clinical Trial
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Status: Enrolling, Phase
Updated: 12/31/1969
Cardiac Transplantation Laboratory, The Victor Chang Cardiac Research Institute
mi
from
Darlinghurst,
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Elkridge, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Lincoln, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Neratinib in Treating Older Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Corona
mi
from
Corona, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Neratinib in Treating Older Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Rancho Cucamonga
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercury Clinical Research
mi
from
Webster, TX
Click here to add this to my saved trials
Healthy Clinical Trial
Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy Subjects
Status: Enrolling, Phase I
Updated: 2/11/2016
QLON Phase 1 Clinic
mi
from
London,
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 4/4/2017
Clinical Research Facility
mi
from
Arizona, AZ
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 293
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 406
mi
from
Austin, TX
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 409
mi
from
Brookhaven, MS
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 166
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Clinical Site 403
mi
from
Denver, CO
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 402
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 420
mi
from
New Bern, NC
Click here to add this to my saved trials
Spinal Stenosis Clinical Trial
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
Status: Enrolling, Phase
Updated: 12/31/1969
Center for Spine Care
mi
from
Dallas, TX
Click here to add this to my saved trials
Spinal Stenosis Clinical Trial
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
Status: Enrolling, Phase
Updated: 12/31/1969
Center for Neurology and Spine
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Chonnam National University Hwasun Hospital
mi
from
Hwasun,
Click here to add this to my saved trials
Metastatic Breast Cancer (MBC) Clinical Trial
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Hyperkalemia Clinical Trial
POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
K. Dieffenbach, M.D.
mi
from
'Aiea, HI
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
George Sun, MD
mi
from
Arcadia, CA
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
CosmetiCare
mi
from
Corona Del Mar, CA
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Dr. Richard Edison
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Carl R. Coers, MD
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Itzhak Nir, MD
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Southwest Plastic Surgery
mi
from
Lubbock, TX
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Ismael Labrador, MD
mi
from
Miami, FL
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Mt. Kisco Medical Group
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Lowcountry Plastic Surgery Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Hospital of the University of Pennsylvania, Penn Plastic Surgery
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
William Beaumont Gresse Pte
mi
from
Saint Clair Shores, MI
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
BodyAesthetic Plastic Surgery
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
AJG Aesthetics
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Mancoll Cosmetic and Plastic Surgery
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Davinci Plastic Surgery
mi
from
Washington DC,
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Plastic and Reconstructive Surgeons
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Wilmington Plastic Surgery
mi
from
Wilmington, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Clarksville, TN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Columbiana, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Edgewater, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Fall River, MA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Washington, MO
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Debary, FL
Click here to add this to my saved trials